JP2001515522A - ポリマーキャリア - Google Patents

ポリマーキャリア

Info

Publication number
JP2001515522A
JP2001515522A JP53697199A JP53697199A JP2001515522A JP 2001515522 A JP2001515522 A JP 2001515522A JP 53697199 A JP53697199 A JP 53697199A JP 53697199 A JP53697199 A JP 53697199A JP 2001515522 A JP2001515522 A JP 2001515522A
Authority
JP
Japan
Prior art keywords
polymer
pla
bioactive
complex
solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP53697199A
Other languages
English (en)
Japanese (ja)
Inventor
ジェイ． ドムブ、アブラハム
ゼハヴィ、ゼーヴ
Original Assignee
エフラット バイオポリマーズ リミティッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by エフラット バイオポリマーズ リミティッド filed Critical エフラット バイオポリマーズ リミティッド
Publication of JP2001515522A publication Critical patent/JP2001515522A/ja
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1641—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, poloxamers
    • A61K9/1647—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
JP53697199A 1998-01-14 1999-01-14 ポリマーキャリア Ceased JP2001515522A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL122933 1998-01-14
IL12293398A IL122933A (en) 1998-01-14 1998-01-14 Polymeric carrier for delivery of a bioactive molecule
PCT/IL1999/000023 WO1999036100A2 (fr) 1998-01-14 1999-01-14 Excipient polymere

Publications (1)

Publication Number Publication Date
JP2001515522A true JP2001515522A (ja) 2001-09-18

Family

ID=11071088

Family Applications (1)

Application Number Title Priority Date Filing Date
JP53697199A Ceased JP2001515522A (ja) 1998-01-14 1999-01-14 ポリマーキャリア

Country Status (6)

Country Link
EP (1) EP0967998A2 (fr)
JP (1) JP2001515522A (fr)
AU (1) AU1888999A (fr)
CA (1) CA2283648C (fr)
IL (1) IL122933A (fr)
WO (1) WO1999036100A2 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006088248A1 (fr) * 2005-02-18 2006-08-24 Nof Corporation Derive de polyoxyalkylene
JP5216995B2 (ja) * 2006-02-03 2013-06-19 国立大学法人北海道大学 ブロック共重合体からなるナノディスク
JPWO2012005376A1 (ja) * 2010-07-09 2013-09-05 国立大学法人 東京大学 核酸送達用組成物及び担体組成物、それを用いた医薬組成物、並びに核酸送達方法
JP2021054738A (ja) * 2019-09-30 2021-04-08 鳥居薬品株式会社 舌下アレルゲン免疫療法におけるフィルム製剤

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2831900A (en) 1999-02-19 2000-09-04 Universiteit Utrecht Stereocomplex hydrogels
JP2002537343A (ja) * 1999-02-23 2002-11-05 アイシス・ファーマシューティカルス・インコーポレーテッド 多重粒子製剤
WO2002083166A1 (fr) * 2001-04-10 2002-10-24 Santen Pharmaceutical Co., Ltd. Complexes de polymeres d'interferons et leur utilisation medicinale
DE10154924A1 (de) * 2001-11-08 2003-05-28 Medinnova Ges Med Innovationen Bioabbaubare Kopolymere
EA008244B1 (ru) * 2002-05-03 2007-04-27 Янссен Фармацевтика Н.В. Полимерные микроэмульсии
EP1902084A2 (fr) * 2005-06-01 2008-03-26 Yissum Research Development Company, of The Hebrew University of Jerusalem Polymeres biodegradables a chiralite predeterminee
PL2135887T3 (pl) 2008-06-18 2011-05-31 Inst Biopolimerow I Wlokien Chemicznych Sposób wytwarzania stereokompleksu polikwasu mlekowego w postaci proszku
CN108559084B (zh) * 2018-04-13 2020-12-04 华东理工大学 一种聚乳酸基疏水薄膜的制备方法
CN109908106A (zh) * 2019-03-04 2019-06-21 北京化工大学 一种可供静脉注射的甲氨蝶呤纳米胶囊及其制备方法
CN115785471B (zh) * 2022-12-16 2023-08-08 华中科技大学 一种二氧化碳基超分子聚合物及其制备方法和应用

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6136321A (ja) * 1984-07-27 1986-02-21 Daicel Chem Ind Ltd 新規なポリマ−およびその樹脂組成物
JPH04501109A (ja) * 1988-10-12 1992-02-27 イー・アイ・デユポン・ドウ・ヌムール・アンド・カンパニー ポリラクチド組成物
JPH05103838A (ja) * 1990-07-19 1993-04-27 Univ Kentucky Res Found タンパク質又はポリペプチドと疎水性生物分解性ポリマーとの相互作用を包含する薬物投与システム

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6136321A (ja) * 1984-07-27 1986-02-21 Daicel Chem Ind Ltd 新規なポリマ−およびその樹脂組成物
JPH04501109A (ja) * 1988-10-12 1992-02-27 イー・アイ・デユポン・ドウ・ヌムール・アンド・カンパニー ポリラクチド組成物
JPH05103838A (ja) * 1990-07-19 1993-04-27 Univ Kentucky Res Found タンパク質又はポリペプチドと疎水性生物分解性ポリマーとの相互作用を包含する薬物投与システム

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006088248A1 (fr) * 2005-02-18 2006-08-24 Nof Corporation Derive de polyoxyalkylene
US8012488B2 (en) 2005-02-18 2011-09-06 Nof Corporation Polyoxyalkylene derivative
JP4877225B2 (ja) * 2005-02-18 2012-02-15 日油株式会社 ポリオキシアルキレン誘導体
JP5216995B2 (ja) * 2006-02-03 2013-06-19 国立大学法人北海道大学 ブロック共重合体からなるナノディスク
JPWO2012005376A1 (ja) * 2010-07-09 2013-09-05 国立大学法人 東京大学 核酸送達用組成物及び担体組成物、それを用いた医薬組成物、並びに核酸送達方法
JP5826174B2 (ja) * 2010-07-09 2015-12-02 国立大学法人 東京大学 核酸送達用組成物及び担体組成物、それを用いた医薬組成物、並びに核酸送達方法
JP2021054738A (ja) * 2019-09-30 2021-04-08 鳥居薬品株式会社 舌下アレルゲン免疫療法におけるフィルム製剤
JP7050734B2 (ja) 2019-09-30 2022-04-08 鳥居薬品株式会社 舌下アレルゲン免疫療法におけるフィルム製剤

Also Published As

Publication number Publication date
CA2283648C (fr) 2007-04-17
IL122933A (en) 2005-03-20
IL122933A0 (en) 1998-08-16
WO1999036100A2 (fr) 1999-07-22
CA2283648A1 (fr) 1999-07-22
WO1999036100A3 (fr) 1999-09-23
EP0967998A2 (fr) 2000-01-05
AU1888999A (en) 1999-08-02

Similar Documents

Publication Publication Date Title
US6365173B1 (en) Stereocomplex polymeric carriers for drug delivery
US10300019B2 (en) Biodegradable, semi-crystalline, phase separated, thermoplastic multi block copolymers for controlled release of biologically active compounds
AU2003249317B2 (en) Biodegradable triblock copolymers, synthesis methods therefor, and hydrogels and biomaterials made there from
JP3955759B2 (ja) 有機溶媒に溶解可能なポリ（アルキレンオキサイド）及びポリ（ｐ−ジオキサノン）の生分解性ブロック共重合体及びこれを含有するドラッグデリバリー組成物
JP5981514B2 (ja) タキサン含有両親媒性ブロック共重合体ミセル組成物及びその製造方法
Kissel et al. ABA-triblock copolymers from biodegradable polyester A-blocks and hydrophilic poly (ethylene oxide) B-blocks as a candidate for in situ forming hydrogel delivery systems for proteins
US5543158A (en) Biodegradable injectable nanoparticles
ES2770273T3 (es) Administración inyectable de micropartículas y composiciones para ello
CA2283648C (fr) Excipient polymere
JP3834331B2 (ja) 表面活性剤を含有しない生体再吸収性重合体微小球、その製造及び薬剤としてその応用
JPH09504042A (ja) 生分解性粒子
JPH11513985A (ja) ポリ（エーテル−エステル）ブロックコポリマーを基剤とする感熱生分解性ポリマー
US20060224095A1 (en) Biocompatible polymeric vesicles self assembled from triblock copolymers
WO2009084801A1 (fr) Composition micellaire de copolymère à blocs amphiphiles contenant du taxane et son procédé de fabrication
KR102539414B1 (ko) 저분자량의 양친성 블록 공중합체를 포함하는 나노입자의 제조 방법
WO2023177300A1 (fr) Copolymères multiblocs à base de poly(ortho-ester) thermoplastique biodégradable
Puri Novel functionalized polymers for nanoparticle formulations with anti cancer drugs
CN113861403A (zh) 一种纳米材料及其制备方法和应用
Lanz Landázuri Modification of microbial polyacids for drug delivery systems
NZ620392B2 (en) Biodegradable, semi-crystalline, phase separated, thermoplastic multi block copolymers for controlled release of biologically active compounds

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20060112

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20091117

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100212

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100319

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100310

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100419

A313 Final decision of rejection without a dissenting response from the applicant

Free format text: JAPANESE INTERMEDIATE CODE: A313

Effective date: 20100607

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100713